PROCEPT BioRobotics (PRCT) Current Leases (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Current Leases data on file, last reported at $2.4 million in Q1 2026.

• On a quarterly basis, Current Leases rose 18.91% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 18.91% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 15.92% from the prior year.
• Current Leases for Q1 2026 stood at $2.4 million, up from $2.2 million in the prior quarter.
• Over the last five years, Current Leases for PRCT reached as high as $3.0 million in Q1 2023 and fell as low as $1.7 million in Q4 2023.
• Historically, Current Leases has averaged $2.1 million across 5 years, with a median of $2.1 million in 2022.
• Across the five-year window, Current Leases surged 37.46% in 2023 and sank 43.26% in 2024, its largest moves.
• Year by year, Current Leases stood at $2.1 million in 2022, then fell by 20.95% to $1.7 million in 2023, then climbed by 13.49% to $1.9 million in 2024, then increased by 15.92% to $2.2 million in 2025, then climbed by 6.5% to $2.4 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $2.4 million in Q1 2026, $2.2 million in Q4 2025, and $2.1 million in Q3 2025.